Omega-3-Supplemented Fat Diet Drives Immune Metabolic Response in Visceral Adipose Tissue by Modulating Gut Microbiota in a Mouse Model of Obesity

Obesity is a chronic, relapsing, and multifactorial disease characterized by excessive accumulation of adipose tissue (AT), and is associated with inflammation mainly in white adipose tissue (WAT) and an increase in pro-inflammatory M1 macrophages and other immune cells. This milieu favors the secre...

Full description

Bibliographic Details
Main Authors: Néstor D. Portela, Cristian Galván, Liliana M. Sanmarco, Gastón Bergero, Maria P. Aoki, Roxana C. Cano, Susana A. Pesoa
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/15/6/1404
_version_ 1797609697247756288
author Néstor D. Portela
Cristian Galván
Liliana M. Sanmarco
Gastón Bergero
Maria P. Aoki
Roxana C. Cano
Susana A. Pesoa
author_facet Néstor D. Portela
Cristian Galván
Liliana M. Sanmarco
Gastón Bergero
Maria P. Aoki
Roxana C. Cano
Susana A. Pesoa
author_sort Néstor D. Portela
collection DOAJ
description Obesity is a chronic, relapsing, and multifactorial disease characterized by excessive accumulation of adipose tissue (AT), and is associated with inflammation mainly in white adipose tissue (WAT) and an increase in pro-inflammatory M1 macrophages and other immune cells. This milieu favors the secretion of cytokines and adipokines, contributing to AT dysfunction (ATD) and metabolic dysregulation. Numerous articles link specific changes in the gut microbiota (GM) to the development of obesity and its associated disorders, highlighting the role of diet, particularly fatty acid composition, in modulating the taxonomic profile. The aim of this study was to analyze the effect of a medium-fat-content diet (11%) supplemented with omega-3 fatty acids (D2) on the development of obesity, and on the composition of the GM compared with a control diet with a low fat content (4%) (D1) over a 6-month period. The effect of omega-3 supplementation on metabolic parameters and the modulation of the immunological microenvironment in visceral adipose tissue (VAT) was also evaluated. Six-weeks-old mice were adapted for two weeks and then divided into two groups of eight mice each: a control group D1 and the experimental group D2. Their body weight was recorded at 0, 4, 12, and 24 weeks post-differential feeding and stool samples were simultaneously collected to determine the GM composition. Four mice per group were sacrificed on week 24 and their VAT was taken to determine the immune cells phenotypes (M1 or M2 macrophages) and inflammatory biomarkers. Blood samples were used to determine the glucose, total LDL and HDL cholesterol LDL, HDL and total cholesterol, triglycerides, liver enzymes, leptin, and adiponectin. Body weight measurement showed significant differences at 4 (D1 = 32.0 ± 2.0 g vs. D2 = 36.2 ± 4.5 g, <i>p</i>-value = 0.0339), 12 (D1 = 35.7 ± 4.1 g vs. D2 = 45.3 ± 4.9 g, <i>p</i>-value = 0.0009), and 24 weeks (D1 = 37.5 ± 4.7 g vs. D2 = 47.9 ± 4.7, <i>p</i>-value = 0.0009). The effects of diet on the GM composition changed over time: in the first 12 weeks, α and β diversity differed considerably according to diet and weight increase. In contrast, at 24 weeks, the composition, although still different between groups D1 and D2, showed changes compared with previous samples, suggesting the beneficial effects of omega-3 fatty acids in D2. With regard to metabolic analysis, the results did not reveal relevant changes in biomarkers in accordance with AT studies showing an anti-inflammatory environment and conserved structure and function, which is in contrast to reported findings for pathogenic obesity. In conclusion, the results suggest that the constant and sustained administration of omega-3 fatty acids induced specific changes in GM composition, mainly with increases in <i>Lactobacillus</i> and <i>Ligilactobacillus</i> species, which, in turn, modulated the immune metabolic response of AT in this mouse model of obesity.
first_indexed 2024-03-11T06:04:31Z
format Article
id doaj.art-bd4485c640c04364a6c73ad75c8a043a
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-11T06:04:31Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-bd4485c640c04364a6c73ad75c8a043a2023-11-17T13:05:18ZengMDPI AGNutrients2072-66432023-03-01156140410.3390/nu15061404Omega-3-Supplemented Fat Diet Drives Immune Metabolic Response in Visceral Adipose Tissue by Modulating Gut Microbiota in a Mouse Model of ObesityNéstor D. Portela0Cristian Galván1Liliana M. Sanmarco2Gastón Bergero3Maria P. Aoki4Roxana C. Cano5Susana A. Pesoa6Departamento de Diagnóstico Molecular, LACE Laboratorios, Córdoba X5000JJS, ArgentinaDepartamento de Diagnóstico Molecular, LACE Laboratorios, Córdoba X5000JJS, ArgentinaCentro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI), Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), Córdoba X5000HUA, ArgentinaCentro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI), Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), Córdoba X5000HUA, ArgentinaCentro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI), Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), Córdoba X5000HUA, ArgentinaUnidad Asociada Área Ciencias Agrarias, Ingeniería, Ciencias Biológicas y de la Salud, Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), Facultad de Ciencias Químicas, Universidad Católica de Córdoba, Córdoba X5016DHK, ArgentinaDepartamento de Diagnóstico Molecular, LACE Laboratorios, Córdoba X5000JJS, ArgentinaObesity is a chronic, relapsing, and multifactorial disease characterized by excessive accumulation of adipose tissue (AT), and is associated with inflammation mainly in white adipose tissue (WAT) and an increase in pro-inflammatory M1 macrophages and other immune cells. This milieu favors the secretion of cytokines and adipokines, contributing to AT dysfunction (ATD) and metabolic dysregulation. Numerous articles link specific changes in the gut microbiota (GM) to the development of obesity and its associated disorders, highlighting the role of diet, particularly fatty acid composition, in modulating the taxonomic profile. The aim of this study was to analyze the effect of a medium-fat-content diet (11%) supplemented with omega-3 fatty acids (D2) on the development of obesity, and on the composition of the GM compared with a control diet with a low fat content (4%) (D1) over a 6-month period. The effect of omega-3 supplementation on metabolic parameters and the modulation of the immunological microenvironment in visceral adipose tissue (VAT) was also evaluated. Six-weeks-old mice were adapted for two weeks and then divided into two groups of eight mice each: a control group D1 and the experimental group D2. Their body weight was recorded at 0, 4, 12, and 24 weeks post-differential feeding and stool samples were simultaneously collected to determine the GM composition. Four mice per group were sacrificed on week 24 and their VAT was taken to determine the immune cells phenotypes (M1 or M2 macrophages) and inflammatory biomarkers. Blood samples were used to determine the glucose, total LDL and HDL cholesterol LDL, HDL and total cholesterol, triglycerides, liver enzymes, leptin, and adiponectin. Body weight measurement showed significant differences at 4 (D1 = 32.0 ± 2.0 g vs. D2 = 36.2 ± 4.5 g, <i>p</i>-value = 0.0339), 12 (D1 = 35.7 ± 4.1 g vs. D2 = 45.3 ± 4.9 g, <i>p</i>-value = 0.0009), and 24 weeks (D1 = 37.5 ± 4.7 g vs. D2 = 47.9 ± 4.7, <i>p</i>-value = 0.0009). The effects of diet on the GM composition changed over time: in the first 12 weeks, α and β diversity differed considerably according to diet and weight increase. In contrast, at 24 weeks, the composition, although still different between groups D1 and D2, showed changes compared with previous samples, suggesting the beneficial effects of omega-3 fatty acids in D2. With regard to metabolic analysis, the results did not reveal relevant changes in biomarkers in accordance with AT studies showing an anti-inflammatory environment and conserved structure and function, which is in contrast to reported findings for pathogenic obesity. In conclusion, the results suggest that the constant and sustained administration of omega-3 fatty acids induced specific changes in GM composition, mainly with increases in <i>Lactobacillus</i> and <i>Ligilactobacillus</i> species, which, in turn, modulated the immune metabolic response of AT in this mouse model of obesity.https://www.mdpi.com/2072-6643/15/6/1404obesityimmune-metabolismadipose tissue macrophagesgut microbiotaOmega-3high fat diet
spellingShingle Néstor D. Portela
Cristian Galván
Liliana M. Sanmarco
Gastón Bergero
Maria P. Aoki
Roxana C. Cano
Susana A. Pesoa
Omega-3-Supplemented Fat Diet Drives Immune Metabolic Response in Visceral Adipose Tissue by Modulating Gut Microbiota in a Mouse Model of Obesity
Nutrients
obesity
immune-metabolism
adipose tissue macrophages
gut microbiota
Omega-3
high fat diet
title Omega-3-Supplemented Fat Diet Drives Immune Metabolic Response in Visceral Adipose Tissue by Modulating Gut Microbiota in a Mouse Model of Obesity
title_full Omega-3-Supplemented Fat Diet Drives Immune Metabolic Response in Visceral Adipose Tissue by Modulating Gut Microbiota in a Mouse Model of Obesity
title_fullStr Omega-3-Supplemented Fat Diet Drives Immune Metabolic Response in Visceral Adipose Tissue by Modulating Gut Microbiota in a Mouse Model of Obesity
title_full_unstemmed Omega-3-Supplemented Fat Diet Drives Immune Metabolic Response in Visceral Adipose Tissue by Modulating Gut Microbiota in a Mouse Model of Obesity
title_short Omega-3-Supplemented Fat Diet Drives Immune Metabolic Response in Visceral Adipose Tissue by Modulating Gut Microbiota in a Mouse Model of Obesity
title_sort omega 3 supplemented fat diet drives immune metabolic response in visceral adipose tissue by modulating gut microbiota in a mouse model of obesity
topic obesity
immune-metabolism
adipose tissue macrophages
gut microbiota
Omega-3
high fat diet
url https://www.mdpi.com/2072-6643/15/6/1404
work_keys_str_mv AT nestordportela omega3supplementedfatdietdrivesimmunemetabolicresponseinvisceraladiposetissuebymodulatinggutmicrobiotainamousemodelofobesity
AT cristiangalvan omega3supplementedfatdietdrivesimmunemetabolicresponseinvisceraladiposetissuebymodulatinggutmicrobiotainamousemodelofobesity
AT lilianamsanmarco omega3supplementedfatdietdrivesimmunemetabolicresponseinvisceraladiposetissuebymodulatinggutmicrobiotainamousemodelofobesity
AT gastonbergero omega3supplementedfatdietdrivesimmunemetabolicresponseinvisceraladiposetissuebymodulatinggutmicrobiotainamousemodelofobesity
AT mariapaoki omega3supplementedfatdietdrivesimmunemetabolicresponseinvisceraladiposetissuebymodulatinggutmicrobiotainamousemodelofobesity
AT roxanaccano omega3supplementedfatdietdrivesimmunemetabolicresponseinvisceraladiposetissuebymodulatinggutmicrobiotainamousemodelofobesity
AT susanaapesoa omega3supplementedfatdietdrivesimmunemetabolicresponseinvisceraladiposetissuebymodulatinggutmicrobiotainamousemodelofobesity